RT Journal Article SR Electronic T1 Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance JF ERJ Open Research JO erjor FD European Respiratory Society SP 00012-2022 DO 10.1183/23120541.00012-2022 VO 8 IS 4 A1 Antoine Beurnier A1 Youri Yordanov A1 Agnès Dechartres A1 Aurélien Dinh A1 Erwan Debuc A1 François-Xavier Lescure A1 Patrick Jourdain A1 Luc Jaulmes A1 Marc Humbert YR 2022 UL http://openres.ersjournals.com/content/8/4/00012-2022.abstract AB Background The prognosis of asthmatic outpatients with COVID-19 needs to be clarified. The objectives of this study were: 1) to investigate the characteristics and outcomes of asthmatic patients receiving initial ambulatory care and home monitoring for COVID-19 with Covidom, a telesurveillance solution; and 2) to compare the characteristics and outcomes between asthmatic and non-asthmatic patients.Methods Inclusion criteria were age ≥18 years, suspected or confirmed COVID-19 diagnosis allowing initial ambulatory care, registration in Covidom between March 2020 and April 2021 and completion of the initial medical questionnaire. We compared clinical characteristics and outcomes between asthmatic and non-asthmatic patients, and we evaluated whether asthma was independently associated with clinical worsening (hospitalisation or death) within 30 days follow-up using a multivariate logistic regression model.Results 33 815 patients met the inclusion criteria. Asthma was reported in 4276 (12.6%). The main comorbidities among asthmatic patients were obesity (23.1%), hypertension (12.7%) and diabetes (4.5%). As compared with non-asthmatic patients, asthmatic patients were more often female (70.0 versus 62.1%, p<0.001), of younger age (42.2 versus 43.8 years, p<0.001) and obese (23.1 versus 17.6%, p<0.001). The rate of hospitalisation did not differ significantly (4.7 versus 4.2%, p=0.203) and no asthmatic patient died during follow-up (versus 25 non-asthmatic patients, 0.1%; p=0.109). In multivariate analysis, asthma was independently associated with higher risk of clinical worsening (OR 1.23, 95% CI 1.04–1.44, p=0.013).Conclusion In a large French cohort of patients receiving initial ambulatory care and home monitoring for COVID-19, asthma was independently associated with higher risk of clinical worsening although no asthmatic patient died within the 30 days follow-up.Asthma appears independently associated with clinical worsening in outpatients receiving ambulatory care for #COVID19 using the Covidom telesurveillance solution for home monitoring but no death was reported among asthmatics https://bit.ly/3vMTzpZ